Lifeline Biotechnologies, Inc. (LLBO)
Lifeline Biotechnologies, Inc. operates in the Medical - Specialties industry of the Healthcare sector, headquartered in Reno, NV, US. The stock last traded at $0.00, up 12.50% on the session, giving a market capitalisation of $3.9M. On trailing twelve-month figures it carries a trailing P/E of -67.13, a net margin of 0.0%. Its beta of -3.53 implies it has historically moved less than the broad market.
Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast; and OVASCOPE, an ultra slim endoscope to directly visualize the ovarian surface in the search for cancer. The company also has operations in Europe. Lifeline Biotechnologies, Inc. was incorporated in 1981 and is headquartered in Reno, Nevada.
Lifeline Biotechnologies, Inc. is most often compared with the following Healthcare names: